Agmatine vs. Memantine: Two NMDA Antagonists with Very Different Risk Profiles
Agmatine and memantine both target NMDA receptors, but via different mechanisms and with very different safety profiles. Here’s what the evidence shows.
Agmatine and memantine both target NMDA receptors, but via different mechanisms and with very different safety profiles. Here’s what the evidence shows.
Learn what third-party testing and a Certificate of Analysis mean for agmatine supplements, and how to verify purity, potency, and safety before you buy.
Compare agmatine powder vs capsules for bioavailability, dosing flexibility, and convenience. Evidence-based guide with honest caveats.
How agmatine sulfate interacts with nitric oxide synthase isoforms, what preclinical research shows, and what bodybuilders should realistically expect.
A look at the only published RCT on agmatine for low back pain from lumbar disc-associated radiculopathy, its mechanism, and what the evidence actually shows.
Agmatine is generally considered safe for most healthy adults at typical doses (500-2,000 mg/day), but the research base is still
Preclinical research, primarily in rodents, has demonstrated agmatine’s neuroprotective effects in models of cerebral ischemia, neuroinflammation, and traumatic brain injury.
How gut bacteria make agmatine, how the intestine absorbs it, and what current research—including cautionary findings—says about agmatine gut health and the mic
Agmatine and citrulline both appear in pump formulas, but act through distinct pathways. Here’s what the evidence actually shows about each.
A science-based look at agmatine dosage ranges for pain, neuroprotection, mood, and cardiovascular support—with honest notes on evidence limits.
How agmatine may reduce anxiety through imidazoline receptors, nitric oxide signaling, and NMDA modulation—an evidence-based preclinical overview.